Skip to main content

Table 2 Percentage change in malaria cases, admissions and deaths, and test positivity rate in 2015 period 1 compared to pre-scale-up period (2005–2010) period 1, by epidemiological zone in given number of health facilities (HF) with complete data 2005–2015, Ghana

From: Effect of anti-malarial interventions on trends of malaria cases, hospital admissions and deaths, 2005–2015, Ghana

Stratum No of HFs Indicator All ages Under 5
Baseline Observed values Observed relative change (%) Predicted relative change compared to baseline (%) Baseline Observed values Observed relative change (%) Predicted relative change compared to baseline (%)
Ave (2005−2010) P1 2015 P1 2015 P1 2015 P1 Ave (2005−2010) P1 2015 P1 2015 P1 2015 1
Coastal 30 Outpatient malaria cases 215,920 193,102 −11 −57 (−71 to −37) 42,069 43,377 3 −52 (−70 to −25)
Malaria admissions 17,722 17,607 −1 −40 (−58 to −14) 7596 8284 9 −26 (−49 to 7)
Malaria deaths 505 181 −64 −68 (−84 to −35) 192 56 −71 −57 (−76 to −22)
Anaemia inpatients 3773 4985 32 14 (−37 to 107) 1509 1879 25 4 (−55 to 144)
Anaemia deaths 205 281 37 74 (12 to 171) 82 64 −21 39 (−8 to 109)
Tested (Mic) 89,297 136,568 53 25 (−31 to 129) 46,182 135,576 194  
Positive (Mic) 29,615 42,550 44 −16 (−40 to 16) 24,319 57,544 137  
Test positivity rate (mic) 34 31 −9 −33 (−58 to 7) 54 42 −22  
Proportion of outpatients 29 21 −28 −23 (−43 to 2) 46 30 −34 −31 (−43 to −17)
Proportion of inpatients 21 16 −24 −34 (−55 to −3) 47 34 −28 −36 (−46 to −24)
Proportion of deaths 17 5 −72 −76 (−90 to −42) 29 7 −77 −73 (−86 to −47)
Non-malaria outpatient 718,045 871,851 21 −45 (−64 to −17) 68,351 86,222 26 −42 (−68 to 3)
Non-malaria inpatients 67,327 94,489 40 0 (−17 to 21) 8499 16,124 90 61 (14 to 128)
Non-malaria deaths 2493 3622 45 56 (8 to 127) 462 769 66 100 (22 to 229)
Forest 30 Outpatient malaria cases 235,523 197,145 −16 −57 (−65 to −48) 50,020 51,668 3 −46 (−62 to −25)
Malaria admissions 19,887 31,406 58 −27 (−46 to −1) 8162 12,748 56 −44 (−70 to 5)
Malaria deaths 222 89 −60 −67 (−78 to −49) 101 31 −69 −81 (−88 to −69)
Anaemia inpatients 3597 11,377 216 32 (−9 to 92) 1887 4280 127 8 (−36 to 81)
Anaemia deaths 142 165 16 −20 (−63 to 72) 43 42 −2 −45 (−77 to 31)
24 Tested (Mic) 28,702 29,626 3 −70 (−89 to −15) 10,518 25,094 139  
Positive (Mic) 6184 4896 −21 −66 (−83 to −30) 3152 3448 9  
Test positivity rate (mic) 22 17 −26 13 (−32 to 87) 30 14 −54  
30 Proportion of outpatients 37 19 −49 −50 (−60 to −38) 52 29 −44 −46 (−57 to −31)
Proportion of inpatients 26 25 −2 −28 (−49 to 1) 51 41 −20 −44 (−53 to −31)
Proportion of deaths 7 4 −46 −41 (−61 to −12) 14 8 −40 −40 (−70 to 20)
Non-malaria outpatient 634,600 1037,746 64 −14 (−33 to 11) 93,083 173,324 86 −3 (−22 to 21)
Non-malaria inpatients 56,415 91,878 63 15 (−26 to 79) 7704 18,677 142 76 (16 to 166)
Non-malaria deaths 2795 2132 −24 −41 (−64 to −5) 613 335 −45 −66 (−80 to −42)
Savannah 28 Outpatient malaria cases 183,718 191,659 4 −59 (−73 to −39) 53,330 60,632 14 −51 (−70 to −20)
Malaria admissions 22,460 42,412 89 −48 (−77 to 19) 10,517 17,825 69 −54 (−85 to 41)
Malaria deaths 502 362 −28 −64 (−79 to −38) 276 147 −47 −70 (−86 to −39)
Anaemia inpatients 3241 7642 136 −30 (−94 to 659) 1686 3086 83 −45 (−94 to 370)
Anaemia deaths 110 226 106 59 (−41 to 329) 54 52 −4 −49 (−85 to 79)
18 Tested (Mic) 21,471 40,977 91 −28 (−55 to 16) 24,823 33,395 35  
Positive (Mic) 8910 13,435 51 −55 (−77 to −9) 11,613 10,697 −8  
Test positivity rate (mic) 42 33 −21 −37 (−61 to 2) 47 32 −32  
28 Proportion of outpatients 46 33 −28 −15 (−34 to 9) 69 50 −27 −5 (−36 to 42)
Proportion of inpatients 30 21 −30 −51 (−66 to −30) 61 28 −54 −55 (−71 to −29)
Proportion of deaths 21 12 −41 −57 (−71 to −35) 40 20 −50 −59 (−71 to −41)
Non-malaria outpatient 396,294 561,263 42 −52 (−67 to −28) 67,199 110,711 65 −52 (−76 to 0)
Non-malaria inpatients 51,207 158,597 210 44 (−19 to 156) 6869 46,089 571 89 (−70 to 1095)
Non-malaria deaths 1887 2586 37 2 (−26 to 40) 421 593 41 14 (−28 to 82)
  1. Negative percentages indicate decrease in the indicator while positive percentages indicate increase during the post-scale up period (2011–2015) compared to the pre-scale-up period
  2. CI with symbol “†” is statistically significant